Top Stories
-
Diagnosed with stage 3 bladder cancer, Jeffrey Pulver underwent chemo, surgery, and a neobladder at Columbia—just in time to walk his daughter down the aisle, cancer-free, on their family farm.
-
Two teams at the Vagelos College of Physicians and Surgeons are working to train patients’ immune cells to seek and destroy rogue cells that cause cancer and autoimmune diseases.
Topic
-
Columbia cell therapy pioneer Michel Sadelain has received the 2025 Merkin Prize in Biomedical Technology and the 2025 King Faisal Prize in Medicine.
Topic
-
Columbia researchers are uncovering potential new therapies to counter the changing identities of cancer cells.
Topic
Latest News
- January 28, 2016
A comprehensive analysis of the molecular characteristics of gliomas—the most common malignant brain tumor—explains why some patients diagnosed with slow-growing (low-grade) tumors quickly succumb to the disease while others with more aggressive (high-grade) tumors survive for many years.
Topic
- January 20, 2016
Researchers have identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.
Topic
- October 12, 2015
Andrea Califano and his investigative team discover a molecular signaling mechanism underlying a specific type of highly aggressive breast cancer.
Topic
